✦ LIBER ✦

Longterm central venous access in gynecologic cancer patients

✍ Scribed by Vatche A Minassian; Anil K Sood; Patrick Lowe; Joel I Sorosky; Adel S Al-Jurf; Richard E Buller

Book ID: 114354113
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 141 KB
Volume: 191
Category: Article
ISSN: 1072-7515
DOI: 10.1016/s1072-7515(00)00690-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient percutaneous central venous a

Outpatient percutaneous central venous access in cancer patients

✍ J. Ralph Broadwater; Michael A. Henderson; John L. Bell; Michael J. Edwards; G. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Peripheral Infusion Ports for Central Ve

Peripheral Infusion Ports for Central Venous Access in Patients with Gynecologic Malignancies

✍ Mary Jadhon Cunningham; Mark B. Collins; Daniel C. Kredentser; John H. Malfetano 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long-term femoral vein central venous ac

Long-term femoral vein central venous access in cancer patients

✍ Sergio Bertoglio; Carmine DiSomma; Paolo Meszaros; Marco Gipponi; Ferdinando Caf 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Externalized Groshong Catheters and Hick

Externalized Groshong Catheters and Hickman Ports for Central Venous Access in Gynecologic Oncology Patients

✍ N.C. Gleeson; J.V. Fiorica; J.E. Mark; D.M. Pinelli; M.S. Hoffman; W.S. Roberts; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 305 KB

P. A. S. Port venous access in gynecolog

P. A. S. Port venous access in gynecologic/oncology patients

✍ C. Pippitt; V. Jobson 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Subcutaneously implanted central venous

Subcutaneously implanted central venous access devices in cancer patients : A prospective analysis

✍ Roderich E. Schwarz; Jeffrey S. Groeger; Daniel G. Coit 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

patients. This analysis was designed to determine device-related morbidity and factors predictive of poor long term outcome for patients with subcutaneous single